Affymetrix, Broad Institute Collaborate for The Cancer Genome Atlas | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix today announced a collaboration with the Broad Institute to chart the genomic changes in more than 20 cancer types as part of the Broad's work on The Cancer Genome Atlas.

About 13,500 cancer samples will be processed on the Affymetrix Genome-wide Human SNP 6.0 Array as part of the partnership. Copy number variation and somatic events will also be studied using the array, as will determining the loss of heterozygosity.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.

Sponsored by
Agilent Technologies

This online seminar will discuss a metagenomic assay to identify viruses and other pathogenic microorganisms in human tumor samples, with the aim of gaining a more comprehensive understanding of the role of the microbiome in cancer development and treatment.